Related references
Note: Only part of the references are listed.A double-blind placebo-controlled study to evaluate endometrial safety and gynaecological symptoms in women treated for up to 5 years with tamoxifen or placebo - A substudy for IBIS I Breast Cancer Prevention Trial
Tiina Palva et al.
EUROPEAN JOURNAL OF CANCER (2013)
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
Christina Davies et al.
LANCET (2013)
Differentially Expressed Genes in Hirudo medicinalis Ganglia after Acetyl-L-Carnitine Treatment
Giuseppe Federighi et al.
PLOS ONE (2013)
Estrogen synthesis and signaling pathways during aging: from periphery to brain
Jie Cui et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Tissue distribution of 4-hydroxy-N-desmethyltamoxifen and tamoxifen-N-oxide
Jennifer Gjerde et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Beyond trastuzumab: novel therapeutic strategies in HER2-positive metastatic breast cancer
R. Y. Tsang et al.
BRITISH JOURNAL OF CANCER (2012)
Early discontinuation of tamoxifen intake in younger women with breast cancer: Is it time to rethink the way it is prescribed?
Laetitia Huiart et al.
EUROPEAN JOURNAL OF CANCER (2012)
The effect of MELatOnin on Depression, anxietY, cognitive function and sleep disturbances in patients with breast cancer. The MELODY trial: protocol for a randomised, placebo-controlled, double-blinded trial
Melissa Voigt Hansen et al.
BMJ OPEN (2012)
Targeting the insulin-like growth factor receptor pathway in lung cancer: problems and pitfalls
Mary Jo Fidler et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2012)
Haemostatic alterations in a group of canine cancer patients are associated with cancer type and disease progression
Eva B. Andreasen et al.
ACTA VETERINARIA SCANDINAVICA (2012)
Multivitamin Supplement Use and Risk of Breast Cancer: A Meta-Analysis
Agnes L. F. Chan et al.
ANNALS OF PHARMACOTHERAPY (2011)
Evaluation of the Effect of Acetyl L-Carnitine on Experimental Cisplatin Ototoxicity and Neurotoxicity
Dilek Gunes et al.
CHEMOTHERAPY (2011)
Breast Cancer Medications and Vision: Effects of Treatments for Early-stage Disease
Alvin Eisner et al.
CURRENT EYE RESEARCH (2011)
Clinical significance of progesterone receptor and HER2 status in estrogen receptor-positive, operable breast cancer with adjuvant tamoxifen
Yong Wha Moon et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2011)
The effect of oxidized low-density lipoprotein combined with adriamycin on the proliferation of Eca-109 cell line
Hao Li et al.
LIPIDS IN HEALTH AND DISEASE (2011)
Fat burners: nutrition supplements that increase fat metabolism
A. E. Jeukendrup et al.
OBESITY REVIEWS (2011)
Diabetes Mellitus Is Associated with Shortened Activated Partial Thromboplastin Time and Increased Fibrinogen Values
Ying Zhao et al.
PLOS ONE (2011)
Partial Inhibition of Estrogen-Induced Mammary Carcinogenesis in Rats by Tamoxifen: Balance between Oxidant Stress and Estrogen Responsiveness
Bhupendra Singh et al.
PLOS ONE (2011)
Controversies in clinical cancer dormancy
Jonathan W. Uhra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across time
Eric A. Ariazi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Obesity, Inflammation, and Postmenopausal Breast Cancer: Therapeutic Implications
Antonio Maccio et al.
THESCIENTIFICWORLDJOURNAL (2011)
Single Dose Administration of L-Carnitine Improves Antioxidant Activities in Healthy Subjects
Yu Cao et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Metabolic Agents that Enhance ATP can Improve Cognitive Functioning: A Review of the Evidence for Glucose, Oxygen, Pyruvate, Creatine, and L-Carnitine
Lauren Owen et al.
NUTRIENTS (2011)
L-carnitine and cancer cachexia: Clinical and experimental aspects
Renata Silverio et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2011)
Insulin-like Growth Factor-Dependent Proliferation and Survival of Triple-Negative Breast Cancer Cells: Implications for Therapy
Zoe Davison et al.
NEOPLASIA (2011)
Associations between tamoxifen, estrogens, and FSH serum levels during steady state tamoxifen treatment of postmenopausal women with breast cancer
Jennifer Gjerde et al.
BMC CANCER (2010)
Effects of Toremifene and Tamoxifen on Lipid Profiles in Post-menopausal Patients with Early Breast Cancer: Interim Results from a Japanese Phase III Trial
Takeshi Tominaga et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2010)
Alternative Medical Interventions Used in the Treatment and Management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Fibromyalgia
Nicole S. Porter et al.
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE (2010)
Insulin-like Growth Factor-I-stimulated Insulin Receptor Substrate-1 Negatively Regulates Src Homology 2 Domain-containing Protein-tyrosine Phosphatase Substrate-1 Function in Vascular Smooth Muscle Cells
Yashwanth Radhakrishnan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
ErbB2 enhances mammary tumorigenesis, oncogene-independent recurrence and metastasis in a model of IGF-IR-mediated mammary tumorigenesis
Craig I. Campbell et al.
MOLECULAR CANCER (2010)
Mitochondria in the elderly: Is acetylcarnitine a rejuvenator?
Mariana G. Rosca et al.
ADVANCED DRUG DELIVERY REVIEWS (2009)
Prothrombin Time and Partial Thromboplastin Time Assay Considerations
Valerie L. Ng
CLINICS IN LABORATORY MEDICINE (2009)
HER-2 Signaling and Inhibition in Breast Cancer
B. C. Browne et al.
CURRENT CANCER DRUG TARGETS (2009)
Effects of Tamoxifen and Raloxifene on Memory and Other Cognitive Abilities: Cognition in the Study of Tamoxifen and Raloxifene
Claudine Legault et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Carnitine Plasma Levels and Fatigue in Children/Adolescents Receiving Cisplatin, Ifosfamide, or Doxorubicin
Marilyn J. Hockenberry et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2009)
Progression of diethylnitrosamine-induced hepatic carcinogenesis in carnitine-depleted rats
Salim S. Al-Rejaie et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Altered carnitine homeostasis is associated with decreased mitochondrial function and altered nitric oxide signaling in lambs with pulmonary hypertension
Shruti Sharma et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
Pharmacological stimulation of brain carnitine palmitoyl-transferase-1 decreases food intake and body weight
Susan Aja et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2008)
Nutrition, metabolic factors and cancer risk
Laure Dossus et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Effects of osmoprotectants on hyperosmolar stress in cultured human corneal epithelial cells
Rosa M. Corrales et al.
CORNEA (2008)
L-carnitine supplementation attenuates intermittent hypoxia-induced oxidative stress and delays muscle fatigue in rats
Arkadeb Dutta et al.
EXPERIMENTAL PHYSIOLOGY (2008)
Role of PKCε in PGF2α-stimulated MMP-2 secretion from human ciliary muscle cells
Shahid Husain et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2008)
Crosstalk between GH/IGF-I axis and steroid hormones (progesterone, 17β-estradiol) in canine mammary tumours
Felisbina L. Queiroga et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2008)
A role for macroautophagy in protection against 4-hydroxytamoxifen-induced cell death and the development of antiestrogen resistance
Julia S. Samaddar et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Obesity, inflammation, and the potential application of pharmaconutrition
Matt C. Cave et al.
NUTRITION IN CLINICAL PRACTICE (2008)
Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the prostate cancer prevention trial
Marian L. Neuhouser et al.
PROSTATE (2008)
Estrogen receptor genotypes, menopausal status, and the lipid effects of tamoxifen
N. I. Ntukidem et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Protective role of carnitine in breast cancer via decreasing arginase activity and increasing nitric oxide
Hakan Erbas et al.
CELL BIOLOGY INTERNATIONAL (2007)
Reduced plasma free fatty acid availability during exercise: effect on gene expression
Rebecca J. Tunstall et al.
EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY (2007)
Carnitine deficiency provokes cisplatin-induced hepatotoxicity in rats
Abdulhakeem A. Al-Majed
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2007)
Tamoxifen induces oxidative stress and mitochondrial apoptosis via stimulating mitochondrial nitric oxide synthase
Rafal R. Nazarewicz et al.
CANCER RESEARCH (2007)
Triglycerides and the risk of coronary heart disease - 10 158 incident cases among 262 525 participants in 29 Western prospective studies
Nadeem Sarwar et al.
CIRCULATION (2007)
Neuro-bioenergetic concepts in cancer prevention and treatment
Ba X. Hoang et al.
MEDICAL HYPOTHESES (2007)
Ameliorating effect of coenzyme Q(10), riboflavin and niacin in tamoxifen-treated postmenopausal breast cancer patients with special reference to lipids and lipoproteins
Srinivasan Yuvaraj et al.
CLINICAL BIOCHEMISTRY (2007)
Effects of L-acetylcarnitine on cirrhotic patients with hepatic coma: Randomized double-blind, placebo-controlled trial
Mariano Malaguarnera et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinib
F. Cappuzzo et al.
ANNALS OF ONCOLOGY (2006)
Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer
Rita Nahta et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
L-carnitine as an ergogenic aid for patients with chronic obstructive pulmonary disease submitted to whole-body and respiratory muscle training programs
A Borghi-Silva et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2006)
Antioxidant and antiradical activities of L-carnitine
I Gülçin
LIFE SCIENCES (2006)
L-Carnitine ameliorates methotrexate-induced oxidative organ injury and inhibits leukocyte death
G Sener et al.
CELL BIOLOGY AND TOXICOLOGY (2006)
Tamoxifen-induced severe hypertriglyceridaemia and acute pancreatitis
Hakan Alagozlu et al.
CLINICAL DRUG INVESTIGATION (2006)
Cardiovascular health and aromatase inhibitors
Kathleen I. Pritchard et al.
DRUGS (2006)
What survival benefits do premenopausal patients with early breast cancer need to make endocrine therapy worthwhile?
B Thewes et al.
LANCET ONCOLOGY (2005)
Propionyl-L-carnitine improves hemodynamics and metabolic markers of cardiac perfusion during coronary surgery in diabetic patients
R Lango et al.
CARDIOVASCULAR DRUGS AND THERAPY (2005)
Tamoxifen fails to affect central serotonergic tone but increases indices of anxiety in female rhesus macaques
D Mook et al.
PSYCHONEUROENDOCRINOLOGY (2005)
L-carnitine inhibits hepatocarcinogenesis via protection of mitochondria
BJ Chang et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Supplementation of L-carnitine improves mitochondrial enzymes in heart and skeletal muscle of aged rats
S Kumaran et al.
EXPERIMENTAL AGING RESEARCH (2005)
Improvement of visual functions and fundus alterations in early age-related macular degeneration treated with a combination of acetyl-L-carnitine, n-3 fatty acids, and coenzyme Q10
J Feher et al.
OPHTHALMOLOGICA (2005)
Association of tamoxifen (TAM) and TAM metabolite concentrations with self-reported side effects of TAM in women with breast cancer
L Gallicchio et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging
G Cavallini et al.
UROLOGY (2004)
Exploratory open label, randomized study of acetyl- and propionylcarnitine in chronic fatigue syndrome
RCW Vermeulen et al.
PSYCHOSOMATIC MEDICINE (2004)
C75, a fatty acid synthase inhibitor, modulates AMP-activated protein kinase to alter neuronal energy metabolism
LE Landree et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease
SA Montgomery et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2003)
Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress
TM Hagen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Acetyl-L-carnitine infusion increases glucose disposal in type 2 diabetic patients
A Giancaterini et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2000)
The relationship of tamoxifen with dementia, depression, and dependence in activities of daily living in elderly nursing home residents
B Breuer et al.
WOMEN & HEALTH (2000)
Share Paper
